Written by Product segment dynamics in the Neurovascular Devices Market reflect diverse clinical requirements across hemorrhagic and ischemic stroke interventions. Aneurysm coiling and embolization devices captured the largest segment of the market in 2025, accounting for 34.8% of total revenues. This dominant position is reinforced by long-standing physician familiarity, comprehensive clinical safety data, and the continuous evolution of detachable embolic coils, liquid embolic agents, and advanced flow-diverting stents designed to isolate cerebral aneurysms from parent blood vessels.
In contrast, neurothrombectomy devices represent the fastest-growing product category, expanding at an estimated 9.14% CAGR through 2035. The rapid adoption of mechanical thrombectomy hardware—including stent retrievers, aspiration catheters, and separator devices—is propelled by updated clinical practice guidelines endorsing mechanical clot removal within an expanded 24-hour treatment window for acute ischemic stroke patients. Concurrently, cerebral balloon angioplasty and stenting systems generated approximately USD 1.12 billion in 2025, reflecting steady clinical demand for intracranial stent systems in treating symptomatic cerebral artery stenosis.
To secure long-term market advantage, leading device manufacturers are bundling coiling, thrombectomy, and access hardware into comprehensive procedural kits. This commercial strategy simplifies operating room preparation while ensuring consistent device compatibility during high-stakes emergency neurovascular procedures.
Frequently Asked Questions (FAQs)
Q1: Which product segment generated the largest market share in 2025?
Aneurysm coiling and embolization devices captured the largest segment, accounting for 34.8% of total market revenues.
Q2: What is driving the rapid growth of neurothrombectomy devices?
Neurothrombectomy growth is driven by updated clinical guidelines endorsing mechanical clot retrieval within a 24-hour window for acute ischemic stroke.
Q3: What is the role of cerebral balloon angioplasty and stenting systems?
These systems are utilized to treat symptomatic intracranial artery stenosis by expanding narrowed cerebral blood vessels and placing supportive stent structures.